Le Lézard
Classified in: Health, Covid-19 virus
Subject: TDS

FDAnews Announces -- The 16th Annual FDA Inspections vSummit Nov. 16-17, 2021


FALLS CHURCH, Va., Oct. 22, 2021 /PRNewswire-PRWeb/ -- What will an FDA inspection look like in 2022? How does one prepare for the FDA's draft rule on harmonizing the Quality System Regulation with the ISO 13485:2016? What is the best response to FDA enforcement actions?

If one is developing, manufacturing or marketing medical devices, one needs to be able to resolve these critical questions. Find the essential answers and more at the upcoming 16th Annual FDA Inspections vSummit. Join the track dedicated to medical devices for insights from current and former FDA officials, along with other seasoned industry leaders.

During the summit's comprehensive, interactive and expert-led sessions, attendees will jump into the most relevant medical device topics of the moment. Over this two-day vSummit, connect with engaged colleagues and learn from knowledgeable experts. Here's some of what attendees will experience:

There have been tremendous changes to the FDA's inspections process since the start of the COVID-19 pandemic and there are only more to come. Learn the lessons one needs to navigate the ever-changing world of inspections, whether that means a return to on-site inspections or a continued integration of remote processes.

Multi-attendee discounts available!
Significant tuition discounts are available for teams of two or more from the same company.

Virtual Workshop Details:
16th Annual FDA Inspections vSummit
An FDAnews Virtual Summit
Tuesday-Wednesday, Nov. 16-17, 2021
https://wcg.swoogo.com/fda-inspections-summit

Tuition:
Single Attendee - $597.00
Group of 2-4 Attendees (Save 10%) - $527.00
Group of 5-6 Attendees (Save 15%) - $492.00
Group of 7-9 Attendees (Save 20%) - $458.00
Group of 10+ Attendees (Save 25%) - $423.00

Easy Ways to Register:
Online: https://wcg.swoogo.com/fda-inspections-summit
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

Media Contact

Michelle Butler, FDAnews, 703.538.7600, [email protected]

 

SOURCE FDAnews


These press releases may also interest you

at 18:00
The "Prepaid Cards - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Prepaid Cards estimated at US$2 Trillion in the year 2023, is projected to reach a revised size of US$4.1 Trillion by...

at 17:25
Five years after the transformational Merger with Randgold Resources, Barrick Gold Corporation has been restructured and repurposed as a modern mining business with a constantly replenished, global asset base of peerless quality, managed by a team...

at 17:15
The "Australia Plastic Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029" report has been added to  ResearchAndMarkets.com's offering. The Australia Plastic Packaging Market size estimated at USD 2.79...

at 17:05
Trinity Capital Inc.  ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth stage companies, today announced an adjustment to the conversion rate of its 6.00% Convertible Notes due 2025 (the "Convertible...

at 16:40
Vista Outdoor Inc. ("Vista Outdoor", "we", "us" or "our") and Czechoslovak Group a.s. ("CSG") announced today that they have voluntarily withdrawn and re-filed their joint voluntary notice to the Committee on Foreign Investment in the United States...

at 16:35
The Board of Directors of Chimera Investment Corporation announced the declaration of its first quarter cash dividend of $0.11 per common share. The dividend is payable April 30, 2024 to common stockholders of record on April 8, 2024. The ex-dividend...



News published on and distributed by: